Iqvia Holdings: Peers

The FY2024 (Dec) proxy of Iqvia Holdings names 22 peer companies for pay. Among Iqvia Holdings and these peers, CEO pay was 3rd highest of 16 and total shareholder return was 12th highest of 16.

3rd highest of 16in Iqvia Holdings and its pay peers, FY2024 (Dec) by CEO pay:

$6.8M$30.4M

12th highest of 16in Iqvia Holdings and its pay peers, FY2024 (Dec) by total shareholder return:

$52$627

Pay peer group, FY2024 (Dec) proxy

Thermo Fisher Scientific
Eli Lilly & Co
International Business Machines
Accenture
Pfizer
Amgen
Biogen
Gilead Sciences
Merck & Co.
Bristol Myers Squibb
AbbVie
Gartner
Zoetis
Cognizant Technology Solutions
Regeneron Pharmaceuticals
Agilent TechnologiesNot disclosedNot disclosed
Avantor, Inc.Not disclosedNot disclosed
Danaher CorporationNot disclosedNot disclosed
ICON plcNot disclosedNot disclosed
Laboratory Corp of America HoldingsNot disclosedNot disclosed
ModernaNot disclosedNot disclosed
Vertex Pharmaceuticals Inc.Not disclosedNot disclosed
22 companies

Changes by year

FY2023 (Dec) proxy

  • RemovedBausch Health Companies Inc.pay peer group
  • RemovedBoston Scientificpay peer group
  • RemovedFiservpay peer group
  • RemovedJohnsonpay peer group
  • RemovedJohnson &pay peer group
  • RemovedQuest Diagnosticspay peer group
  • RemovedS&P Global Inc.pay peer group
  • RemovedSalesforcepay peer group
  • RemovedThomson Reuters Corp.pay peer group

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.